SEP 8, 2026 · PHASE 3 TRIAL
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
ClinicalTrials.gov
This is a registry record for a Phase 3 trial still recruiting; no results are reported, making evidence assessment impossible at this stage.
Reported
Estimated enrollment800
Study phasePhase 3
Primary outcome measureChange from Baseline in WOMAC Pain Subscale…